Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.60 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.60 |
| ▸ | PTPN7 | P35236 | 3/20 | 0.54 |
| ▸ | HMGCR | P04035 | 3/20 | 0.54 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.50 |
| ▸ | PPARG | P37231 | 5/20 | 0.48 |
| ▸ | PPARD | Q03181 | 5/20 | 0.48 |
| ▸ | PPARA | Q07869 | 5/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL609292 | 1.00 | TSHR (0.60) | TSHRLMNAHSD17B10CYP1A2CYP2D6 | |
| SCHEMBL3761638 | 1.00 | TSHR (0.60) | TSHRLMNAHSD17B10CYP1A2CYP2D6 | |
| SCHEMBL4188688 | 1.00 | TSHR (0.60) | TSHRLMNAHSD17B10CYP1A2CYP2D6 | |
| SCHEMBL9351053 | 1.00 | TSHR (0.60) | TSHRLMNAHSD17B10CYP1A2CYP2D6 | |
| SCHEMBL1285460 | 1.00 | TSHR (0.60) | TSHRLMNAHSD17B10CYP1A2CYP2D6 | |
| SCHEMBL9352237 | 1.00 | TSHR (0.60) | TSHRLMNAHSD17B10CYP1A2CYP2D6 | |
| SCHEMBL2210214 | 1.00 | TSHR (0.60) | TSHRLMNAHSD17B10CYP1A2CYP2D6 | |
| Ammonia Solution, Strong SCHEMBL5979550 | 0.98 | HSD17B10 (0.58) | TSHRLMNAHSD17B10CYP1A2CYP2D6 | |
| SCHEMBL454017 | 0.97 | — | — | |
| Adipic Acid SCHEMBL9504707 | 0.97 | LMNA (0.58) | TSHRLMNAHSD17B10CYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117393768-B | Positive electrode material for sodium ion battery, preparation method of positive electrode material and sodium ion battery | 天鹏锂能技术(淮安)有限公司 | 2024-08-27 | — | — | CN | claimed |
| CN-117393768-A | Positive electrode material for sodium ion battery, preparation method of positive electrode material and sodium ion battery | 天鹏锂能技术(淮安)有限公司 | 2024-01-12 | — | — | CN | claimed |
| CN-117080450-B | Positive pole piece of sodium ion battery and sodium ion battery | 江苏天鹏电源有限公司 | 2023-12-26 | — | — | CN | claimed |
| CN-117080450-A | Positive pole piece of sodium ion battery and sodium ion battery | 江苏天鹏电源有限公司 | 2023-11-17 | — | — | CN | claimed |
| CN-117393768-B | Positive electrode material for sodium ion battery, preparation method of positive electrode material and sodium ion battery | 天鹏锂能技术(淮安)有限公司 | 2024-08-27 | — | — | CN | disclosed |
| US-12037463-B2 | Antimicrobial ophthalmic devices comprising polysiloxane-polyglycerol block copolymers and methods of making and use thereof | Clearlab Sg Pte Ltd. (SG) | 2024-07-16 | — | — | US | disclosed |
| US-12024597-B2 | Wound dressings comprising polysiloxane-polyglycerol block copolymers and methods of making and use thereof | Clearlab Sg Pte Ltd. (SG) | 2024-07-02 | — | — | US | disclosed |
| CN-117393768-A | Positive electrode material for sodium ion battery, preparation method of positive electrode material and sodium ion battery | 天鹏锂能技术(淮安)有限公司 | 2024-01-12 | — | — | CN | disclosed |
| CN-117080450-B | Positive pole piece of sodium ion battery and sodium ion battery | 江苏天鹏电源有限公司 | 2023-12-26 | — | — | CN | disclosed |
| CN-117080450-A | Positive pole piece of sodium ion battery and sodium ion battery | 江苏天鹏电源有限公司 | 2023-11-17 | — | — | CN | disclosed |
| WO-2023184791-A1 | METHOD FOR ENZYMATIC SYNTHESIS OF BRIVARACETAM CHIRAL INTERMEDIATE | 浙江工业大学 | 2023-10-05 | — | — | WO | disclosed |
| US-20230227613-A1 | ANTIMICROBIAL OPHTHALMIC DEVICES COMPRISING POLYSILOXANE-POLYGLYCEROL BLOCK COPOLYMERS AND METHODS OF MAKING AND USE THEREOF | CLEARLAB SG PTE LTD (SG) | 2023-07-20 | — | — | US | disclosed |
| US-20030212290-A1 | Asymmetric synthesis of pregabalin | BURK MARK JOSEPH (US) | 2003-11-13 | — | — | US | disclosed |
| EP-1250311-A1 | ASYMMETRIC SYNTHESIS OF PREGABALIN | WARNER-LAMBERT COMPANY (US) | 2002-10-23 | — | — | EP | disclosed |
| WO-2001055090-A1 | ASYMMETRIC SYNTHESIS OF PREGABALIN | WARNER-LAMBERT COMPANY (US) | 2001-08-02 | — | — | WO | disclosed |
| EP-0730574-B1 | PROCESSES AND CATALYST COMPOSITIONS FOR HYDROCYANATION OF MONOOLEFINS | DU PONT (US) | 1998-08-19 | — | — | EP | disclosed |
| US-5723641-A | PHOSPHITE CATALYSTS FOR HYDROCYANATION | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1998-03-03 | — | — | US | disclosed |
| US-5688986-A | CATALYTIC HYDROCYANATION OF NONCONJUGATED ACYCLIC ALIPHATIC MONOOLEFIN, MONOOLEFIN CONJUGATED TO ESTER OR MONOOLEFIN CONJUGATED TO CYANIDE IN THE PRESENCE OF NICKEL PHOSPHITE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-11-18 | — | — | US | disclosed |
| EP-0730574-A1 | PROCESSES AND CATALYST COMPOSITIONS FOR HYDROCYANATION OF MONOOLEFINS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-09-11 | — | — | EP | disclosed |
| WO-1995014659-A1 | PROCESSES AND CATALYST COMPOSITIONS FOR HYDROCYANATION OF MONOOLEFINS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-06-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030212290-A1 | Asymmetric synthesis of pregabalin | GABRA5, GABRA6, GABRE | TSHR 4184/4885LMNA 4428/4885HSD17B10 114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.